|
P1-093 O-T02B-2649
Biomaterials processing and biofabrication
-
Bioprinting and bionik
Photocrosslinkable Nanocomposite Hydrogel for Vascularized Liver Tissue Embedded Bioprinting
Jaemyung Shin
|
|
P1-094 P-T02A-4226
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
Rheological Assessment and 3D Printing Performance of Plant Protein-Based High Internal Phase Pickering Emulsions for Customized Food Design
Napat Tomano
|
|
P1-095 O-T02B-3428
Biomaterials processing and biofabrication
-
Bioprinting and bionik
Novel Bioink Carrier Formulations for 3D Bioprinting of Skeletal Muscle
Laurence Meagher
|
|
P1-097 E-T03A-0794
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Cryo-enhanced upconversion photodynamic therapy
Anara Molkenova
|
|
P1-098 P-T03A-0684
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Inhibition of Residual Colorectal Cancer Growth After Surgery Using Muco-adhesive and Anti-fouling Janus Film.
Jaebeom Lee
|
|
P1-100 P-T03A-3026
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Biodegradable Polymer-based Multifunctional Porous Microspheres Loaded with Oncolytic bacteria for Targeted Cancer Therapy
Gahyun Bae
|
|
P1-101 P-T03A-2670
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Activating Natural Killer Cells for Cancer Immunotherapy Using Cationic Nanoparticle
Joo Dong Park
|
|
P1-102 P-T03A-3266
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Investigating the Synergistic Effects of Immunostimulatory Nanoparticles and Electrical Ablation for Enhanced Cancer Immunotherapy
Seungyong Shin
|
|
P1-103 P-T03A-3610
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Hybrid Nanovesicles in Cancer Therapy: Innovations in Targeted Photodynamic Treatment
SeungHyo Ko
|
|
P1-104 P-T03A-1389
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Development of light-activatable nanogels for phototherapy of cancer
Subin Lee
|
|
P1-105 P-T03A-1583
Biomaterials for theranostics
-
Biomaterials for cancer therapy
"3-in-1" multifunctional platform biomaterials for NK surface membrane immobilization of cancer targeting ligands and gemcitabine chemodrug in pancreatic cancer treatment
Jaewon Park
|
|
P1-106 E-T03A-1578
Biomaterials for theranostics
-
Biomaterials for cancer therapy
NK cell surface decoration of anti-PDL1 peptides using lipid-conjugate biomaterials for augmented cancer immunotherapy
Kyung Mu Noh
|
|
P1-107 P-T03A-1558
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Visible shifts in fluidity and adhesiveness of a pH-responsive nanoparticle-based conductive hydrogel for cancer detection and therapy
Kaustuv Roy
|
|
P1-108 P-T03A-0723
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Immune-Modulating Magnetic Nanoparticles to Enhance the activity of Dendritic cells for Treatment of Breast Cancer
Jaesung Lim
|
|
P1-109 P-T03A-2886
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Enhancing adoptive macrophage-based cancer therapy through sustained M1 phenotype maintenance by TLR7/8 agonists
Yeon Jeong Yoo
|
|
P1-110 P-T03A-3376
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Tumor targeted ROS-sensitizing metal laden Polymeric Nanoparticles
Geum Byeol Park
|
|
P1-111 P-T03A-0669
Biomaterials for theranostics
-
Biomaterials for cancer therapy
KRAS-Mutated Pancreatic Cancer Treatment through Immunogenic Cell Death and Phagocytosis Dendritic Cell using Antibody-Photosensitizer Conjugate
SooMin Cho
|
|
P1-112 P-T03A-0656
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Triterpenoid aglycone modification for targeted photodynamic therapy: overcoming limitation of current photosensitizer
Seohee Kim
|
|
P1-113 E-T03A-0479
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Near-infrared light responsive biocompatible Ag2S Nanodots for theragnosis
Mou Seung Kim
|
|
P1-114 E-T03A-0524
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Biopolymeric Nanoparticle-based Inhaled Gene Delivery for Targeted Treatment of Pulmonary Cancer
Yun Seop Shim
|
|
P1-115 P-T03A-2481
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Targeted Degradation of NRF2 Transcription Factor by dNRF2 Oligonucleotide PROTAC Inhibits Chemoresistance to Drugs Inducing Ferroptosis and Apoptosis
Yejin Lee
|
|
P1-116 P-T03A-2480
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Targeted Ferroptosis Modulation in Cancer Immunotherapy via Iron Oxide Nanoparticle-Encapsulated PD-L1 siRNA
Suhyun Ryu
|
|
P1-117 P-T03A-0459
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Enhanced chemo-sonodynamic therapy using exosome-coated MnO2 nanoparticles with self-oxygenation and glycolytic inhibition abilities
Anh H. V. Nguyen
|
|
P1-118 P-T03A-2665
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Enhanced anticancer efficacy through intratumoral injection of doxorubicin-loaded hyaluronic acid hydrogel
kyungeun Son
|
|
P1-119 P-T03A-3960
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Targeting matrix mechanics curbs oral carcinogenesis by interfering with non-canonical Hedgehog signaling
Ali Taghizadeh
|
|
P1-120 E-T03A-2210
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Hyaluronic Acid-Squalene based nanoclusters for colon cancer that promotes ferroptosis along with radiation
Raveena Nagareddy
|
|
P1-121 O-T03A-3013
Biomaterials for theranostics
-
Biomaterials for cancer therapy
A mild reduction of cell surface inhibits migratory behaviors of tongue cancers via an integrin α5β1-FAK axis
Laurensia Danis Anggradita
|
|
P1-122 P-T03A-1597
Biomaterials for theranostics
-
Biomaterials for cancer therapy
VEGF-based Peptide for Targeting of Angiogenesis
Kevin Kent Vincent Canlas
|
|
P1-123 E-T03A-3421
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Membrane-disrupting helical polypeptide induces immune priming and delivers IL-12 mRNA to facilitate synergistic cancer immunotherapy
Susam Lee
|
|
P1-124 E-T03A-2885
Biomaterials for theranostics
-
Biomaterials for cancer therapy
Phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment
Susam Lee
|
Login
